Allergan's competitors

Allergan's competitors include Acceleron Pharma, Bristol-Myers Squibb, Novartis and Pfizer
Add company...
Allergan
Allergan is a global pharmaceutical company.
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Novartis
Novartis provides healthcare solutions that address the evolving needs of patients and societies.
Pfizer
Pfizer is a biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
Founding Date
Founding Date
1948
Founding Date
2003
Founding Date
1887
Founding Date
1996
Founding Date
1849
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Dublin, IE HQ
Parsippany Troy Hills, US
Locations
Cambridge, US HQ
Locations
New York, US HQ
Bi, DE
Lawrence Township, US
Devens, US
Hopewell, US
Mulhuddart, IE
Zug, CH
see more
Locations
Basel, CH HQ
Beijing, CN
Wehr, DE
Tokyo, JP
New York, US
East Hanover, US
Locations
New York, US HQ
Buenos Aires, AR
Melrose Park, AU
Wien, AT
Minsk, BY
Ixelles, BE
Sofia, BG
see more
Employees
Employees
16,700 46% decrease
Employees
121
Employees
23,700 5% decrease
Employees
121,597
Employees
90,200 7% decrease
Valuation ($)
Valuation ($)
59.3 b
Valuation ($)
1.5 b
Valuation ($)
86 b
Valuation ($)
N/A
Valuation ($)
221.1 b
Facebook likes
Facebook likes
219
Facebook likes
N/A
Facebook likes
120.2 k
Facebook likes
304.3 k
Facebook likes
320.2 k
Twitter followers
Twitter followers
23 k
Twitter followers
499
Twitter followers
120.8 k
Twitter followers
234.4 k
Twitter followers
13.3 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$13.5m (FY, 2017)
Revenue (est.)
$19.4b (FY, 2016)
Revenue (est.)
$48.5b (FY, 2016)
Revenue (est.)
$52.8b (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$4.9b (FY, 2016)
Cost of goods
$17.5b (FY, 2016)
Cost of goods
$12.3b (FY, 2016)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$14.5b (FY, 2016)
Gross profit
$31b (FY, 2016)
Gross profit
$40.5b (FY, 2016)
Net income
Net income
N/A
Net income
($108.5m) (FY, 2017)
Net income
$4.5b (FY, 2016)
Net income
$6.7b (FY, 2016)
Net income
$7.2b (FY, 2016)

Operating

Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
8 (Y, 2016)
Phase III Trials Products
29 (Y, 2016)
Phase III Trials Products
34 (Y, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles